Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00032955 · ClinicalTrials.gov registry record · Phase 3
Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1
A Phase 3 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 3
- Development phase
- 163
- Enrollment target
NCT00032955 is a Phase 3 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 163 participants.
The verdict
NCT00032955, a Phase 3 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 163 participants
- Enrollment target
Study Summary
The purpose of this study is to assess buprenorphine/naloxone versus clonidine for inpatient opiate detoxification.
Interventions
- DRUG Buprenorphine/naloxone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2001-02 |
| Est. Completion | 2002-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00032955
The ClinicalTrials.gov registry entry for NCT00032955 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine/naloxone is the first listed.
NCT00032955 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00032955 about?
NCT00032955 is a clinical study titled "Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1". The purpose of this study is to assess buprenorphine/naloxone versus clonidine for inpatient opiate detoxification.
What is the current status of trial NCT00032955?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 163 participants. The study started on 2001-02. Estimated completion is 2002-08.
What interventions are being tested in trial NCT00032955?
The interventions under investigation include: Buprenorphine/naloxone (DRUG).
Who is sponsoring clinical trial NCT00032955?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.